Acute lymphoblastic leukaemia - inotuzumab ozogamicin - initial (induction) authority application form (PB269)

Use this form to apply for initial (induction) PBS-subsidised inotuzumab ozogamicin treatment for acute lymphoblastic leukaemia.

Page last updated: 1 March 2026.
QC 49941